AstraZeneca PLC
NYSE: AZN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Pascal Claude Roland Soriot
- Employees
- 94,300
- Headquarters
- Cambridge, United Kingdom
- IPO year
- 1993
- Market cap
- $285.1B
- Website
- https://www.astrazeneca.com
Loading AZN…
Loading profile data…Frequently asked questions about AZN
What does AstraZeneca PLC (AZN) do?
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort,...
Where does AZN trade?
AstraZeneca PLC (AZN) trades on the New York Stock Exchange.
What sector is AZN in?
AstraZeneca PLC (AZN) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of AstraZeneca PLC?
Pascal Claude Roland Soriot is the chief executive officer of AstraZeneca PLC (AZN).
Where is AstraZeneca PLC headquartered?
AstraZeneca PLC is headquartered in United Kingdom.
When did AZN go public?
AstraZeneca PLC (AZN) completed its initial public offering in 1993.
Is AZN an ADR?
Yes — AZN is an American Depositary Receipt; its underlying shares trade on a non-US exchange. AstraZeneca PLC reporting and dividends follow the underlying issuer.